We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Immunohistochemistry Assesses Early Response in Acute Myeloid Leukemia

By LabMedica International staff writers
Posted on 26 Aug 2015
Acute myeloid leukemia (AML) is a heterogeneous disease with respect to prognosis and early response assessment has an established role as predictor of remission rate, and overall and disease-free survival.

Among the large number of prognostic factors for AML, karyotype is one of the best predictors of remission rates and survival and it has been incorporated in a number of risk stratification models. More...
Even after this risk assignment based on cytogenetics, the prognosis of individual patient remains largely unknown as some patients in the high-risk category do well, while the opposite is true for others.

Hematologists at the All India Institute of Medical Sciences (New Delhi, India) conducted an observational, prospective, and retrospective study of a total of 100 cases of AML who received induction therapy and had a Day+14 and Day+28 bone marrow aspiration and biopsy were included in the study. Only those cases which had hematopoietic progenitor cell antigen CD34 positive blasts in flow cytometry at initial diagnosis were included.

Immunohistochemistry was performed to enumerate blasts using the antibody against CD34 on Day+14 bone marrow trephine biopsy. The determination of the blast percentage on CD34 stained Day+14 bone marrow biopsy (BMB) sections was performed manually. For this, five representative fields were selected and CD34 positive cells were counted under the oil immersion lens (× 1000). The pattern of CD34 positivity was a granular brown cytoplasmic and membranous staining. The blast percentage on D+14 bone marrow aspirate (BMA) was compared with the blast count obtained on the CD34 immunostained same day marrow biopsy sections.

CD34 immunohistochemistry (IHC) performed on D+14 BMB showed brown granular cytoplasmic staining in blasts which was clearly distinguishable from the normal hematopoietic cells, lymphocytes, and other negative cells in the background. On CD34 IHC, 67 cases had a blast count of equal to or less than 5%, 22 cases with a count of greater than 5% to 20%, and 11 cases with a count greater than 20%. On BMA, 82/100 patients were staged as good responders, CD34 IHC assessment confirmed 67 out if these 82 as good responders, but reassigned 15 of them into intermediate and poor responders.

The authors concluded that early response assessment plays an important role in management of acute myeloid leukemia. In patients with CD34-positive blasts, the CD34 IHC can improve the detection of residual blasts on Day 14 bone marrow biopsies in comparison with morphological assessment of blast percentage in bone marrow aspirates. The study was published online on August 6, 2015, in the International Journal of Laboratory Hematology.

Related Links:

All India Institute of Medical Sciences 



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.